an article written by amy madsen for mda s quest magazine describes a pilot trial using clenbuterol for a treatment for kennedy s disease sbma to read the entire article , follow this link clenbuterol study summary of trial results from a person pilot trial suggest that clenbuterol may improve motor and respiratory function in people with spinal bulbar muscular atrophy , but safety concerns were raised article highlights treatment with a drug called clenbuterol was well tolerated and was correlated with an increase in walking distance and respiratory capacity in a person , open label pilot study in italy in people with spinal bulbar muscular atrophy sbma during the trial , muscle strength did not improve , and an indicator of ongoing muscle damage increased in blood samples clenbuterol , which belongs to a class of drugs called beta agonists , is approved in some countries for treatment of asthma or other breathing disorders , but is not approved by the u s food and drug administration to treat human conditions or diseases in the united states study investigators suggest that additional clinical trials to test the therapeutic potential of clenbuterol , or similar beta agonist drugs , in people with sbma may be warranted